Related references
Note: Only part of the references are listed.Specificity Influences in (1→3)-β-d-Glucan-Supported Diagnosis of Invasive Fungal Disease
Malcolm A. Finkelman
JOURNAL OF FUNGI (2021)
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly et al.
CLINICAL INFECTIOUS DISEASES (2020)
D-Index-Guided Early Antifungal Therapy Versus Empiric Antifungal Therapy for Persistent Febrile Neutropenia: A Randomized Controlled Noninferiority Trial
Yoshinobu Kanda et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Real-world management of infection during chemotherapy for acute leukemia in Japan: from the results of a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group
Shun-ichi Kimura et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2020)
Efficacy and safety of micafungin in empiric and D-index-guided early antifungal therapy for febrile neutropenia; A subgroup analysis of the CEDMIC trial
Shun-ichi Kimura et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Management of infection during chemotherapy for acute leukemia in Japan: a nationwide questionnaire-based survey by the Japan Adult Leukemia Study Group
Shun-ichi Kimura et al.
SUPPORTIVE CARE IN CANCER (2017)
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2016)
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
Thomas F. Patterson et al.
CLINICAL INFECTIOUS DISEASES (2016)
A comprehensive diagnostic approach using galactomannan, targeted β-D-glucan, baseline computerized tomography and biopsy yields a significant burden of invasive fungal disease in at risk haematology patients
M. Mansour Ceesay et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia
Monica Fung et al.
PLoS One (2015)
Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial
C. Orla Morrissey et al.
LANCET INFECTIOUS DISEASES (2013)
Efficacy and safety of micafungin as an empirical antifungal therapy for suspected fungal infection in neutropenic patients with hematological disorders
Minoru Yoshida et al.
ANNALS OF HEMATOLOGY (2012)
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
Alison G. Freifeld et al.
CLINICAL INFECTIOUS DISEASES (2011)
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database
Dimitrios P. Kontoyiannis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Improved survival from fungaemia in patients with haematological malignancies: Analysis of risk factors for death and usefulness of early antifungal therapy
Atsushi Iwama et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Empirical versus Preemptive Antifungal Therapy for High-Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial
Catherine Cordonnier et al.
CLINICAL INFECTIOUS DISEASES (2009)
Clinical Practice Guidelines for the Management of Candidiasis: 2009 Update by the Infectious Diseases Society of America
Peter G. Pappas et al.
CLINICAL INFECTIOUS DISEASES (2009)
Management of infection in patients with acute leukemia during chemotherapy in Japan: questionnaire analysis by the Japan Adult Leukemia Study Group
Hiroyuki Fujita et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
Utility of Galactomannan Enzyme Immunoassay and (1,3) beta-D-Glucan in Diagnosis of Invasive Fungal Infections: Low Sensitivity for Aspergillus fumigatus Infection in Hematologic Malignancy Patients
R. Y. Hachem et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders
Kazuo Tamura et al.
LEUKEMIA & LYMPHOMA (2009)
Treatment of aspergillosis: Clinical practice guidelines of the infectious diseases society of America
Thomas J. Walsh et al.
CLINICAL INFECTIOUS DISEASES (2008)
Reappraisal of the serum (1→3)-β-D-glucan assay for the diagnosis of invasive fungal infections -: A study based on autopsy cases from 6 years
Taminori Obayashi et al.
CLINICAL INFECTIOUS DISEASES (2008)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
Presumptive treatment strategy for aspergillosis in allogeneic haematopoietic stem cell transplant recipients
Kumi Oshima et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2007)
Usefulness of determination of β-D-glucan in the diagnosis of deep mycosis -: Experience in Japan
Minoru Yoshida
MEDICAL MYCOLOGY (2006)
Galactomannan and computed tomography - Based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: A prospective feasibility study
J Maertens et al.
CLINICAL INFECTIOUS DISEASES (2005)
Multicenter clinical evaluation of the (1→3) β-D-glucan assay as an aid to diagnosis of fungal infections in humans
L Ostrosky-Zeichner et al.
CLINICAL INFECTIOUS DISEASES (2005)
A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan
S Kohno et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2004)
Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: Variables that affect performance
KA Marr et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Current antimicrobial usage for the management of infections in leukemic patients in Japan: Results of a survey
M Yoshida et al.
CLINICAL INFECTIOUS DISEASES (2004)
β-D-glucan as a diagnostic adjunct for invasive fungal infections:: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome
Z Odabasi et al.
CLINICAL INFECTIOUS DISEASES (2004)
Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis
MASH Mennink-Kersten et al.
LANCET INFECTIOUS DISEASES (2004)
Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked Immunosorbent assay for galactomannan, and a (1→3)-β-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders
M Kawazu et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer
WT Hughes et al.
CLINICAL INFECTIOUS DISEASES (2002)
Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus
S Ascioglu et al.
CLINICAL INFECTIOUS DISEASES (2002)
Share Paper
